OxyContin Maker Purdue Pharma Agrees to Tentative Opioid Lawsuit Settlement

OxyContin maker Purdue Pharma has reached a tentative settlement worth billions of dollars to resolve thousands of lawsuits brought by state and local governments who sued the drug company for its role in the opioid epidemic.

At least 16 state attorneys general said they have not agreed to the deal, NBC News reports.

Under the proposed settlement, the Sackler family, which owns Purdue, would give up control of the company, which would declare bankruptcy. Future revenue from the sale of OxyContin would go into a trust designed to assist communities hard hit by the opioid crisis.

Full story at Partnership for Drug-Free Kids